製药和生物技术领域的共同推广和联合行销（2016-2025）

《製药和生物技术领域的联合促销和联合行销交易》深入理解和分析了公司如何以及为何达成联合促销和联合行销交易。

本报告提供了 2016 年至 2025 年联合推广和联合行销交易的详细资讯。

本报告提供双方宣布的联合促销和联合行销交易的付款条款。这些数据为付款条款和其他贸易条款提供了宝贵的见解。

了解潜在合作伙伴谈判的交易条款的灵活性可以为谈判过程提供重要的见解，让您了解在谈判条款时会发生什么。许多中小企业可能会要求详细的付款条款，但当涉及如何触发付款和权利转移时，细节决定成败。

本报告提供了当前协议交易和合作伙伴关係资料库中记录的自 2016 年以来宣布的联合推广和联合营销交易的综合列表，以及可用的财务条款，以及公司及其合作伙伴向美国证券交易委员会提交的实际联合推广和联合营销交易文件的在线副本链接。

报告的第一章描述了共同推广和联合行销交易和商业活动。

第 1 章对报告进行了介绍，第 2 章对联合促销和联合行销趋势进行了概述和分析，并讨论了每种交易类型的好处。

第 3 章概述了联合促销和联合行销交易结构。

第 4 章回顾了 2016 年以来的主要联合推广和联合行销专案。交易按标题金额列出。如果交易已与美国证券交易委员会 (SEC) 公布了协议，您可以透过此连结透过目前协议交易和联盟资料库在线存取协议。

第 5 章提供了最活跃的 25 家联合推广和联合行销交易商的综合清单。每个交易标题都透过当前协议交易和联盟资料库连结到完整的线上交易记录，并连结到可用的实际协议文件，从而可以轻鬆、按需存取每个交易记录。

第 6 章对 2016 年以来达成或宣布的联合推广和联合行销交易进行了全面深入的回顾，其中提供了合约文件，按公司 A-Z、疗法、技术和行业进行组织。合约文件详细介绍了双方就联合推广和联合行销协议达成的实际条款和条件。

交易目录包含自 2016 年以来宣布的所有联合推广和联合行销交易的综合清单。每个清单都按公司 A-Z、治疗领域和技术类型组织成交易目录。每个交易标题都透过超连结连结到交易记录的线上版本，包括实际的合约文件（如果有）。

该报告还包含大量图表和图形，展示了自 2016 年以来联合推广和联合行销交易的趋势和活动。

总之，我们提供了潜在交易者需要了解的所有关于共同推广和联合行销交易的资讯。

目录

摘要整理

第1章 -简介

第2章 联合促销与联合行销的交易趋势

• 简介
• 联合促销与联合行销交易定义
• 2016年以后的联合促销与联合行销交易趋势
  • 联合促销与联合行销交易数量，各年度，2016年～2025年
  • 联合促销与联合行销交易，各开发阶段，2016年～2025年
  • 联合促销与联合行销交易，2016年～2025年，各业界
  • 联合促销与联合行销交易，2016年～2025年，各治疗领域
  • 联合促销与联合行销交易，2016年～2025年，各技术类型
  • 最活跃的各企业联合促销与联合行销的交易，2016年～2025年
• 为什么要签订共同推广和联合行销合作协议？
• 共同推广与联合行销交易的未来

第3章 联合促销与联合行销的交易结构概要

• 简介
• 联合促销与联合行销交易结构

第4章 联合促销与联合行销交易的主导

• 简介
• 主要的联合促销与联合行销交易，各金额

第5章 -最活跃的联合促销与联合行销的交易厂商主要25公司

• 简介
• 最活跃的联合促销与联合行销的交易厂商主要25公司

第6章 -包含契约名录的联合促销与联合行销交易

• 简介
• 联合促销与联合行销交易，2016年～2025年
• 交易名录
• 交易名录 - 联合促销与联合行销交易(AZ)，各企业
• 交易名录 - 联合促销与联合行销交易，各治疗领域
• 交易名录 - 联合促销与联合行销交易，各科技类型
• 关于调查公司
• 目前联盟
• 目前契约
• Current Partnering的最近报告标题

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter co-promotion and co-marketing deals.

Fully revised and updated, the report provides details of co-promotion and co-marketing deals from 2016 to 2025.

The report provides access to co-promotion and co-marketing deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of co-promotion and co-marketing deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-promotion and co-marketing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of co-promotion and co-marketing dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in co-promotion and co-marketing as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of co-promotion and co-marketing deals.

Chapter 4 provides a review of the leading co-promotion and co-marketing deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active co-promotion and co-marketing dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of co-promotion and co-marketing deals organized by company A-Z, therapy, technology and industry type signed and announced since 2016 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the co-promotion and co-marketing deal.

The deal directory includes a comprehensive listing of all co-promotion and co-marketing deals announced since 2016. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in co-promotion and co-marketing dealmaking since 2016.

In conclusion, this report provides everything a prospective dealmaker needs to know about co-promotion and co-marketing alliances.

Key benefits

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:

• Understand deal trends since 2016
• Browse co-promotion and co-marketing deals
• Benchmark analysis - identify market value of transactions
• Financials terms
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology is intended to provide the reader with an in-depth understanding of the co-promotion and co-marketing trends and structure of deals entered into by leading biopharma companies worldwide.

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology includes:

• Trends in co-promotion and co-marketing dealmaking in the biopharma industry
• Overview of co-promotion and co-marketing deal structure
• Directory of co-promotion and co-marketing deal records covering pharmaceutical and biotechnology
• The leading co-promotion and co-marketing deals by value
• Most active co-promotion and co-marketing dealmakers
• The leading co-promotion and co-marketing partnering resources

In Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for co-promotion and co-marketing deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in co-promotion and co-marketing dealmaking

• 2.1. Introduction
• 2.2. Definition of co-promotion and co-marketing deals
• 2.3. Trends in co-promotion and co-marketing deals since 2016
  • 2.3.1. Co-promotion and co-marketing dealmaking by year, 2016-2025
  • 2.3.2. Co-promotion and co-marketing dealmaking by phase of development, 2016-2025
  • 2.3.3. Co-promotion and co-marketing dealmaking by industry sector, 2016-2025
  • 2.3.4. Co-promotion and co-marketing dealmaking by therapy area, 2016-2025
  • 2.3.5. Co-promotion and co-marketing dealmaking by technology type, 2016-2025
  • 2.3.6. Co-promotion and co-marketing dealmaking by most active company, 2016-2025
• 2.4. Reasons for entering into co-promotion and co-marketing partnering deals
• 2.5. The future of co-promotion and co-marketing deals

Chapter 3 - Overview of co-promotion and co-marketing deal structure

• 3.1. Introduction
• 3.2. Co-promotion and co-marketing agreement structure

Chapter 4 - Leading co-promotion and co-marketing deals

• 4.1. Introduction
• 4.2. Top co-promotion and co-marketing deals by value

Chapter 5 - Top 25 most active co-promotion and co-marketing dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active co-promotion and co-marketing dealmakers

Chapter 6 - Co-promotion and co-marketing deals including contracts directory

• 6.1. Introduction
• 6.2. Co-promotion and co-marketing deals with contracts 2016-2025
• Deal directory
• Deal directory - Co-promotion and co-marketing dealmaking by companies A-Z
• Deal directory - Co-promotion and co-marketing dealmaking by therapy area
• Deal directory - Co-promotion and co-marketing dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of co-promotion and co-marketing
• Figure 2: Trends in co-promotion and co-marketing deal announcements, 2016-2025
• Figure 3: Co-promotion and co-marketing deals signed at each phase of development, 2016-2025
• Figure 4: Co-promotion and co-marketing deals by industry sector, 2016-2025
• Figure 5: Co-promotion and co-marketing deals by therapy area, 2016-2025
• Figure 6: Co-promotion and co-marketing deals by technology type, 2016-2025
• Figure 7: Top 25 most active co-promotion and co-marketing dealmakers, 2016-2025
• Figure 8: Top co-promotion and co-marketing deals by value, 2016-2025
• Figure 9: Most active co-promotion and co-marketing dealmakers, 2016-2025